Archive readyExternal timestamp ready

グループ会社｜株式会社トランスジェニックグループ

https://transgenic-group.co.jp/corporation/group/

April 25, 2026 at 06:20 AM JST•The archive page, viewer, and downloads use this saved version.

April 25, 2026 at 06:20 AM JST·transgenic-group.co.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

External timestamp

The evidence pack includes the third-party timestamp files.

External timestamp

External timestamp ready

Provider

DigiCert RFC3161

TSA time

April 25, 2026 at 08:45 PM JST

Saved page

グループ会社｜株式会社トランスジェニックグループ

Open the archived HTML with saved-time metadata attached.

Original URLhttps://transgenic-group.co.jp/corporation/group/

StartedApril 25, 2026 at 06:20 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page presents the corporate structure of the Transgenic Group. The Drug Discovery Support Business Group provides gene-modified animal production using CRISPR/Cas9 technology, antibody production, and model mouse supply, offering comprehensive support from basic research to clinical trials. The Investment and Consulting Business Group provides advisory and support services for M&A, business succession, and business regeneration. The group comprises 5 companies in drug discovery support and 9 companies in investment and consulting operations across multiple locations in Japan.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.